In recent years, multiple studies demonstrated that GDF-15 levels are associated with the adverse cardiovascular events across a spectrum of CVD conditions including heart failure, chest pain, acute coronary syndrome, stable ischemic heart disease, stroke and atrial fibrillation [6]. The gene discussed is GDF15; the disease is atrial fibrillation.